PBMs Want Separate FTC Hearings Over Insulin Prices
By Matthew Perlman · October 24, 2024, 6:39 PM EDT
Caremark Rx LLC, Express Scripts Inc. and OptumRx Inc. are calling for separate proceedings in the Federal Trade Commission's case accusing the pharmacy benefit managers of artificially inflating insulin prices through...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login